99% up by HPLC IMATINIB MESYLATE 220127-57-1

Name: 99% up by HPLC IMATINIB MESYLATE 220127-57-1
Availability: 99-up-by-hplc-imatinib-mesylate-220127-5-273841.html

Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:99% up by HPLC IMATINIB MESYLATE 220127-57-1
CAS No.:220127-57-1
Standard:USP, BP, EP, JP, In-house Standards
Price(USD):Negotiable
Company:Sinoway Industrial Co.Ltd.

Send Inquiry

Favorites

Product Information

Product name	Imatinib Mesylate
Molecular Formula	C30H35N7O4S
Molecular Weight	589.71
CAS No.	220127-57-1
Quality Standard	In-house standard
Appearance	White powder

COA of Imatinib Mesylate

TEST ITEMS	SPECIFICATION	RESULTS
Appearance	White or slightly yellow crystalline powder, homogeneous and with fine grain size. No foreign particles are observed.	Slightly yellow crystalline Powder
Solubility	Soluble in water and in acids solutions, slightly soluble in methanol insoluble in acetone, acetonitrile and dilute hydroxyl alkaline solution	Confirm
Identification	Complies	Confirm
Water	≤1.0%	0.8%
Heavy metals	≤20ppm	10ppm
Melting range	212 – 220℃	214-216℃
Residue on ignition	≤0.1%	0.08%
Particle size	90% < 100 μm 50% < 50 μm	Confirm
Bulk density	NLT 0.4g/ml	0.6g/ml
Chromatographic purity	Individual impurities: ≤0.2% Total impurities: ≤0.5%	0.16% 0.32%
Assay	98.5%-102.0% of Imatinib mesylate, calculated on anhydrous basis.	99.70%
Residual solvents	Ethyl acetate: ≤5000ppm	Confirm
	Acetone: ≤5000ppm	Confirm
	N,N-Dimethylformamide: ≤880ppm	Confirm
	Methanol: ≤3000ppm	Confirm
	Dichloromethane: ≤300ppm	Confirm

We provide you with high-quality imatinib mesylate powder and imatinib mesylate price is very reasonable and competitive.

Usage

Imatinib mesylate (also called Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl,
the causal agent in chronic myelogenous leukemia.

As an inhibitor of PDGFR, imatinib mesylate appears to have utility in the treatment of a variety of
dermatological diseases. Imatinib has been reported to be an effective treatment for FIP1L1-PDGFRalpha+ mast cell disease, hypereosinophilic syndrome, and dermatofibrosarcoma protuberans.

1. A tyrosine kinase inhibitor. Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL)

2. Echinocandin antifungal, active against infections with Aspergillus and Candida, inhibits cell wall synthesis

3. Anticancer

Send your message to this supplier

From:
To:
Sinoway Industrial Co.Ltd.
Send a Copy to this Email
Message:
Upload Images / Files
- Supports jpg, jpeg, png,
gif, pdf, doc, docx,
xls, xlsx, txt, rar and zip
- Max upload 3 files;
Max total size: 3MB
(0/3)

Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now
Verification:

Other Products from this supplier
More>>

NICOTINAMIDE MONONUCLEOTIDE (NMN) 1094-61-7

STEVIA LEAF EXTRACT 57817-89-7

L-GLUTATHIONE REDUCED (GSH) 70-18-8

NICOTINAMIDE ADENINE DINUCLEOTIDE 58-84-9

ALPHA GPC 28319-77-9

PALMITOYLETHANOLAMIDE (PEA) 544-31-0

PTEROSTILBENE 537-42-8

VONOPRAZAN FUMARATE 1260141-27-2

AZILSARTAN 147403-03-0

LOSARTAN POTASSIUM 124750-99-8

99% up by HPLC IMATINIB MESYLATE 220127-57-1

Product Information

Product name

Imatinib Mesylate

Molecular Formula

C30H35N7O4S

Molecular Weight

589.71

CAS No.

220127-57-1

Quality Standard

In-house standard

Appearance

White powder

COA of Imatinib Mesylate

TEST ITEMS

SPECIFICATION

RESULTS

Appearance

White or slightly yellow crystalline powder, homogeneous and with fine grain size. No foreign particles are observed.

Slightly yellow crystalline Powder

Solubility

Soluble in water and in acids solutions, slightly soluble in methanol insoluble in acetone, acetonitrile and dilute hydroxyl alkaline solution

Confirm

Identification

Complies

Confirm

Water

≤1.0%

0.8%

Heavy metals

≤20ppm

10ppm

Melting range

212 – 220℃

214-216℃

Residue on ignition

≤0.1%

0.08%

Particle size

90% < 100 μm

50% < 50 μm

Confirm

Bulk density

NLT 0.4g/ml

0.6g/ml

Chromatographic

purity

Individual impurities: ≤0.2%

Total impurities: ≤0.5%

0.16%

0.32%

Assay

98.5%-102.0% of Imatinib mesylate,

calculated on anhydrous basis.

99.70%

Residual solvents

Ethyl acetate: ≤5000ppm

Confirm

Acetone: ≤5000ppm

Confirm

N,N-Dimethylformamide: ≤880ppm

Confirm

Methanol: ≤3000ppm

Confirm

Dichloromethane: ≤300ppm

Confirm

We provide you with high-quality imatinib mesylate powder and imatinib mesylate price is very reasonable and competitive.

Usage

Imatinib mesylate (also called Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl, the causal agent in chronic myelogenous leukemia.

As an inhibitor of PDGFR, imatinib mesylate appears to have utility in the treatment of a variety of dermatological diseases. Imatinib has been reported to be an effective treatment for FIP1L1-PDGFRalpha+ mast cell disease, hypereosinophilic syndrome, and dermatofibrosarcoma protuberans.

1. A tyrosine kinase inhibitor. Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL)

2. Echinocandin antifungal, active against infections with Aspergillus and Candida, inhibits cell wall synthesis

3. Anticancer

Other Products from this supplierMore>>

White or slightly yellow crystalline powder,
homogeneous and with fine grain size.
No foreign particles are observed.

Soluble in water and in acids solutions, slightly soluble
in methanol insoluble in acetone, acetonitrile and
dilute hydroxyl alkaline solution

Imatinib mesylate (also called Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl,
the causal agent in chronic myelogenous leukemia.

As an inhibitor of PDGFR, imatinib mesylate appears to have utility in the treatment of a variety of
dermatological diseases. Imatinib has been reported to be an effective treatment for FIP1L1-PDGFRalpha+ mast cell disease, hypereosinophilic syndrome, and dermatofibrosarcoma protuberans.

Other Products from this supplier
More>>